Subha Raman is a Cardiology physician affiliated with OhioHealth. OpenAlex indexes 216 publications with 7,259 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
410 W 10th Ave
Columbus, OH 432101240
Telephone
614-293-7677Provider last certified this registry record 22 Jan 2021.
Clinical trials
- Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Sponsor: Ohio State University
- Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy
Sponsor: Subha Raman
- Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Sponsor: Ohio State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- Boston Scientific CorporationProgram year20241 payment
- Amgen Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Factor Xa inhibitor100%Xarelto100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2005–2020 per NIH RePORTER. The latest:
- Dietary fats, mitochondrial function and muscle health in cancer patients
Ohio State University
FY2020$107,055R21CA209566 - Dietary fats, mitochondrial function and muscle health in cancer patients
Ohio State University
FY2019$54,004R21CA209566
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine
2020 - Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function
JACC. Cardiovascular imaging
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Yvonne Efebera, MD
OhioHealth
Gary Ansel, MD
OhioHealth
Steven Yakubov, MD
OhioHealth
Nirav Vora, MD
OhioHealth
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”